We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
-0.56%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$81.3B
AUM Growth
-$1.18B
Cap. Flow
+$158M
Cap. Flow %
0.19%
Top 10 Hldgs %
39.76%
Holding
963
New
137
Increased
344
Reduced
325
Closed
77

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$967M
2
CRM icon
Salesforce
CRM
+$381M
3
BABA icon
Alibaba
BABA
+$184M
4
CMI icon
Cummins
CMI
+$125M
5
TMUS icon
T-Mobile US
TMUS
+$83.7M

Sector Composition

Rank Sector Weight
1 Technology 27.82%
2 Consumer Discretionary 14.99%
3 Communication Services 14.18%
4 Healthcare 13.76%
5 Industrials 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWE
826
DELISTED
World Wrestling Entertainment
WWE
$9K ﹤0.01%
+161
New +$8.39K
CTXS
827
DELISTED
Citrix Systems Inc
CTXS
$9K ﹤0.01%
84
+3
+4% +$324
DISCK
828
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$9K ﹤0.01%
364
+196
+117% +$5.24K
BIIB icon
829
Biogen
BIIB
$30.7B
$8K ﹤0.01%
30
-44
-59% -$14.4K
CAH icon
830
Cardinal Health
CAH
$55.4B
$8K ﹤0.01%
155
DOX icon
831
Amdocs
DOX
$6.22B
$8K ﹤0.01%
111
DVA icon
832
DaVita
DVA
$11.7B
$8K ﹤0.01%
73
-24
-25% -$3.01K
EAF icon
833
GrafTech
EAF
$212M
$8K ﹤0.01%
80
FICO icon
834
Fair Isaac
FICO
$22.5B
$8K ﹤0.01%
+19
New +$9.04K
OGN icon
835
Organon & Co
OGN
$3.57B
$8K ﹤0.01%
245
-52,786
-100% -$1.69M
RGLD icon
836
Royal Gold
RGLD
$19.5B
$8K ﹤0.01%
+87
New +$9.75K
RKT icon
837
Rocket Companies
RKT
$38.9B
$8K ﹤0.01%
+482
New +$8.43K
RPRX icon
838
Royalty Pharma
RPRX
$25.3B
$8K ﹤0.01%
+228
New +$8.86K
SFM icon
839
Sprouts Farmers Market
SFM
$8.01B
$8K ﹤0.01%
353
TKR icon
840
Timken Company
TKR
$9.03B
$8K ﹤0.01%
115
GAP
841
The Gap Inc
GAP
$7.37B
$8K ﹤0.01%
+364
New +$10.1K
AZPN
842
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$8K ﹤0.01%
+69
New +$8K
AMED
843
DELISTED
Amedisys
AMED
$7K ﹤0.01%
+48
New +$9.98K
FL
844
DELISTED
Foot Locker
FL
$7K ﹤0.01%
164
SAGE
845
DELISTED
Sage Therapeutics
SAGE
$7K ﹤0.01%
+166
New +$7.61K
DEA
846
Easterly Government Properties
DEA
$1.18B
$5K ﹤0.01%
98
+36
+58% +$1.95K
FINV
847
FinVolution Group
FINV
$1.15B
$5K ﹤0.01%
+900
New +$5.93K
O icon
848
Realty Income
O
$59.1B
$5K ﹤0.01%
72
-45
-38% -$3.04K
LEA icon
849
Lear
LEA
$8.18B
$4K ﹤0.01%
26
VSXY
850
Victoria's Secret
VSXY
$7.83B
$3K ﹤0.01%
+51
New +$3.1K

Similar funds

Loomis, Sayles & Company's Q3 2021 Portfolio in Review

As of Q3 2021, Loomis, Sayles & Company held 963 positions worth $81.3B, down 1.4% from $82.5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Loomis, Sayles & Company's Q3 2021 filing shows 137 new, 344 increased, 325 reduced and 77 closed positions. Its largest new stake was Helios Technologies: 474,902 shares worth $39M. The largest sale was Deere & Co, an estimated $748M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q3 2021 buy was Helios Technologies: 474,902 shares worth $39M.
  • Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q3 2021, an estimated $967M increase.
  • Loomis, Sayles & Company's biggest Q3 2021 reduction was Deere & Co, cutting an estimated $748M.
  • Loomis, Sayles & Company fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $116M.
  • Loomis, Sayles & Company's ten largest holdings make up 40% of its $81.3B portfolio in Q3 2021.
  • Loomis, Sayles & Company opened 137 new positions and closed 77 in Q3 2021.
  • Loomis, Sayles & Company's portfolio value fell 1.4% quarter-over-quarter to $81.3B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2021, filed 12 Nov 2021.